Lord, Abbett & Co
ROIV icon

Lord, Abbett & Co’s Roivant Sciences ROIV Stock Holding History

Lord, Abbett & Co’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.33M Buy
+235,403
New +$6.96M 0.02% 406

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Lord, Abbett & Co's ROIV Position: Q2 2026 in Review

Lord, Abbett & Co opened a new position in Roivant Sciences (ROIV) in Q2 2026: 235,403 shares worth $8.33M. The stake represents 0.02% of the portfolio and ranks #406 among its holdings.

498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Lord, Abbett & Co held 235,403 shares of Roivant Sciences worth $8.33M as of Q2 2026.
  • Roivant Sciences was a new Lord, Abbett & Co position in Q2 2026.
  • Roivant Sciences made up 0.02% of Lord, Abbett & Co's portfolio in Q2 2026, its #406 holding.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.